Biotherapeutics Cell Line Development Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Process (Transfection and Selection, Single cell cloning); Option (In-house, Outsource, Hybrid); Application (Clinical Treatment, Scientific Research, Others) and Geography

Report Code: TIPRE00007166 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Biotherapeutic drug products consist of a variety of active ingredients. These compounds are either synthesised or extracted from biological entities. Interleukins, interferons, and other recombinant DNA technologies are used to create these biotherapeutic drug therapy products. These techniques have a number of advantages, including therapeutic protein and peptide efficacy and safety. Biotherapeutic products have proven to be beneficial in the treatment of a variety of chronic and life-threatening disorders in the past. Hematologic illnesses, autoimmune disorders, cancer, hormone dysregulation, genetic abnormalities, and infectious diseases are among the conditions for which biotherapeutic proteins are used. One of the most important advantages of human cell lines is their capacity to become contaminated in a way that is unique to people.

MARKET SCOPE

The "Global Biotherapeutics Cell Line Development Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biotherapeutics cell line development market with detailed market segmentation by process, option and application. The report provides key statistics on the market status of the leading biotherapeutics cell line development market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on process the market is segmented as, transfection & selection, Single cell cloning.
  •   Based on option the market is segmented as, in-house, outsource and hybrid.
  •   Based on application the market is segmented as, clinical treatment, scientific research and others.

MARKET DYNAMICS
Drivers:

  •   Increasing prevalence of chronic disorders such as, cancers, rheumatoid arthritis and diabetes.
  •   Technological advancements in biotherapeutics therapies along with growing demand for biotherapeutics.
  •   Advancements in biopharmaceutical and biotechnology companies along with new launch of biopharmaceutical drugs.
  •   Rising demand for monoclonal antibodies is also expected to have significant growth opportunities for the market.

Restraints:

  •   However, high cost associated with the technology and presence of stringent approval procedures are likley to have negative impact on market growth.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biotherapeutics cell line development market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the biotherapeutics cell line development market in these regions.

IMPACT OF COVID-19 ON BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the biotherapeutics cell line development market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biotherapeutics cell line development market are anticipated to lucrative growth opportunities in the future with the rising demand for biotherapeutics cell line development in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biotherapeutics cell line development market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Beckman Coulter, Inc
  •   Boehringer Ingelheim International GmbH
  •   Catalent, Inc
  •   AGC Biologics
  •   Lonza
  •   Sysmex Europe GmbH
  •   Selexis SA
  •   ProBioGen AG
  •   Thermo Fisher Scientific Inc.
  •   Merck KGaA
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biotherapeutics Cell Line Development Market - By Process
1.3.2 Biotherapeutics Cell Line Development Market - By Option
1.3.3 Biotherapeutics Cell Line Development Market - By Application
1.3.4 Biotherapeutics Cell Line Development Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOTHERAPEUTICS CELL LINE DEVELOPMENT - GLOBAL MARKET OVERVIEW
6.2. BIOTHERAPEUTICS CELL LINE DEVELOPMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - REVENUE AND FORECASTS TO 2028 - PROCESS
7.1. OVERVIEW
7.2. PROCESS MARKET FORECASTS AND ANALYSIS
7.3. TRANSFECTION AND SELECTION
7.3.1. Overview
7.3.2. Transfection and Selection Market Forecast and Analysis
7.4. SINGLE CELL CLONING
7.4.1. Overview
7.4.2. Single cell cloning Market Forecast and Analysis
8. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - REVENUE AND FORECASTS TO 2028 - OPTION
8.1. OVERVIEW
8.2. OPTION MARKET FORECASTS AND ANALYSIS
8.3. IN-HOUSE
8.3.1. Overview
8.3.2. In-house Market Forecast and Analysis
8.4. OUTSOURCE
8.4.1. Overview
8.4.2. Outsource Market Forecast and Analysis
8.5. HYBRID
8.5.1. Overview
8.5.2. Hybrid Market Forecast and Analysis
9. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CLINICAL TREATMENT
9.3.1. Overview
9.3.2. Clinical Treatment Market Forecast and Analysis
9.4. SCIENTIFIC RESEARCH
9.4.1. Overview
9.4.2. Scientific Research Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Biotherapeutics Cell Line Development Market Overview
10.1.2 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis
10.1.3 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
10.1.4 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
10.1.5 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Application
10.1.6 North America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
10.1.6.1 United States Biotherapeutics Cell Line Development Market
10.1.6.1.1 United States Biotherapeutics Cell Line Development Market by Process
10.1.6.1.2 United States Biotherapeutics Cell Line Development Market by Option
10.1.6.1.3 United States Biotherapeutics Cell Line Development Market by Application
10.1.6.2 Canada Biotherapeutics Cell Line Development Market
10.1.6.2.1 Canada Biotherapeutics Cell Line Development Market by Process
10.1.6.2.2 Canada Biotherapeutics Cell Line Development Market by Option
10.1.6.2.3 Canada Biotherapeutics Cell Line Development Market by Application
10.1.6.3 Mexico Biotherapeutics Cell Line Development Market
10.1.6.3.1 Mexico Biotherapeutics Cell Line Development Market by Process
10.1.6.3.2 Mexico Biotherapeutics Cell Line Development Market by Option
10.1.6.3.3 Mexico Biotherapeutics Cell Line Development Market by Application
10.2. EUROPE
10.2.1 Europe Biotherapeutics Cell Line Development Market Overview
10.2.2 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis
10.2.3 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
10.2.4 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
10.2.5 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Application
10.2.6 Europe Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Biotherapeutics Cell Line Development Market
10.2.6.1.1 Germany Biotherapeutics Cell Line Development Market by Process
10.2.6.1.2 Germany Biotherapeutics Cell Line Development Market by Option
10.2.6.1.3 Germany Biotherapeutics Cell Line Development Market by Application
10.2.6.2 France Biotherapeutics Cell Line Development Market
10.2.6.2.1 France Biotherapeutics Cell Line Development Market by Process
10.2.6.2.2 France Biotherapeutics Cell Line Development Market by Option
10.2.6.2.3 France Biotherapeutics Cell Line Development Market by Application
10.2.6.3 Italy Biotherapeutics Cell Line Development Market
10.2.6.3.1 Italy Biotherapeutics Cell Line Development Market by Process
10.2.6.3.2 Italy Biotherapeutics Cell Line Development Market by Option
10.2.6.3.3 Italy Biotherapeutics Cell Line Development Market by Application
10.2.6.4 Spain Biotherapeutics Cell Line Development Market
10.2.6.4.1 Spain Biotherapeutics Cell Line Development Market by Process
10.2.6.4.2 Spain Biotherapeutics Cell Line Development Market by Option
10.2.6.4.3 Spain Biotherapeutics Cell Line Development Market by Application
10.2.6.5 United Kingdom Biotherapeutics Cell Line Development Market
10.2.6.5.1 United Kingdom Biotherapeutics Cell Line Development Market by Process
10.2.6.5.2 United Kingdom Biotherapeutics Cell Line Development Market by Option
10.2.6.5.3 United Kingdom Biotherapeutics Cell Line Development Market by Application
10.2.6.6 Rest of Europe Biotherapeutics Cell Line Development Market
10.2.6.6.1 Rest of Europe Biotherapeutics Cell Line Development Market by Process
10.2.6.6.2 Rest of Europe Biotherapeutics Cell Line Development Market by Option
10.2.6.6.3 Rest of Europe Biotherapeutics Cell Line Development Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Biotherapeutics Cell Line Development Market Overview
10.3.2 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis
10.3.3 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
10.3.4 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
10.3.5 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Biotherapeutics Cell Line Development Market
10.3.6.1.1 Australia Biotherapeutics Cell Line Development Market by Process
10.3.6.1.2 Australia Biotherapeutics Cell Line Development Market by Option
10.3.6.1.3 Australia Biotherapeutics Cell Line Development Market by Application
10.3.6.2 China Biotherapeutics Cell Line Development Market
10.3.6.2.1 China Biotherapeutics Cell Line Development Market by Process
10.3.6.2.2 China Biotherapeutics Cell Line Development Market by Option
10.3.6.2.3 China Biotherapeutics Cell Line Development Market by Application
10.3.6.3 India Biotherapeutics Cell Line Development Market
10.3.6.3.1 India Biotherapeutics Cell Line Development Market by Process
10.3.6.3.2 India Biotherapeutics Cell Line Development Market by Option
10.3.6.3.3 India Biotherapeutics Cell Line Development Market by Application
10.3.6.4 Japan Biotherapeutics Cell Line Development Market
10.3.6.4.1 Japan Biotherapeutics Cell Line Development Market by Process
10.3.6.4.2 Japan Biotherapeutics Cell Line Development Market by Option
10.3.6.4.3 Japan Biotherapeutics Cell Line Development Market by Application
10.3.6.5 South Korea Biotherapeutics Cell Line Development Market
10.3.6.5.1 South Korea Biotherapeutics Cell Line Development Market by Process
10.3.6.5.2 South Korea Biotherapeutics Cell Line Development Market by Option
10.3.6.5.3 South Korea Biotherapeutics Cell Line Development Market by Application
10.3.6.6 Rest of Asia-Pacific Biotherapeutics Cell Line Development Market
10.3.6.6.1 Rest of Asia-Pacific Biotherapeutics Cell Line Development Market by Process
10.3.6.6.2 Rest of Asia-Pacific Biotherapeutics Cell Line Development Market by Option
10.3.6.6.3 Rest of Asia-Pacific Biotherapeutics Cell Line Development Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Biotherapeutics Cell Line Development Market Overview
10.4.2 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis
10.4.3 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
10.4.4 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
10.4.5 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Biotherapeutics Cell Line Development Market
10.4.6.1.1 South Africa Biotherapeutics Cell Line Development Market by Process
10.4.6.1.2 South Africa Biotherapeutics Cell Line Development Market by Option
10.4.6.1.3 South Africa Biotherapeutics Cell Line Development Market by Application
10.4.6.2 Saudi Arabia Biotherapeutics Cell Line Development Market
10.4.6.2.1 Saudi Arabia Biotherapeutics Cell Line Development Market by Process
10.4.6.2.2 Saudi Arabia Biotherapeutics Cell Line Development Market by Option
10.4.6.2.3 Saudi Arabia Biotherapeutics Cell Line Development Market by Application
10.4.6.3 U.A.E Biotherapeutics Cell Line Development Market
10.4.6.3.1 U.A.E Biotherapeutics Cell Line Development Market by Process
10.4.6.3.2 U.A.E Biotherapeutics Cell Line Development Market by Option
10.4.6.3.3 U.A.E Biotherapeutics Cell Line Development Market by Application
10.4.6.4 Rest of Middle East and Africa Biotherapeutics Cell Line Development Market
10.4.6.4.1 Rest of Middle East and Africa Biotherapeutics Cell Line Development Market by Process
10.4.6.4.2 Rest of Middle East and Africa Biotherapeutics Cell Line Development Market by Option
10.4.6.4.3 Rest of Middle East and Africa Biotherapeutics Cell Line Development Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Biotherapeutics Cell Line Development Market Overview
10.5.2 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis
10.5.3 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Process
10.5.4 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Option
10.5.5 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Application
10.5.6 South and Central America Biotherapeutics Cell Line Development Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Biotherapeutics Cell Line Development Market
10.5.6.1.1 Brazil Biotherapeutics Cell Line Development Market by Process
10.5.6.1.2 Brazil Biotherapeutics Cell Line Development Market by Option
10.5.6.1.3 Brazil Biotherapeutics Cell Line Development Market by Application
10.5.6.2 Argentina Biotherapeutics Cell Line Development Market
10.5.6.2.1 Argentina Biotherapeutics Cell Line Development Market by Process
10.5.6.2.2 Argentina Biotherapeutics Cell Line Development Market by Option
10.5.6.2.3 Argentina Biotherapeutics Cell Line Development Market by Application
10.5.6.3 Rest of South and Central America Biotherapeutics Cell Line Development Market
10.5.6.3.1 Rest of South and Central America Biotherapeutics Cell Line Development Market by Process
10.5.6.3.2 Rest of South and Central America Biotherapeutics Cell Line Development Market by Option
10.5.6.3.3 Rest of South and Central America Biotherapeutics Cell Line Development Market by Application

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. BIOTHERAPEUTICS CELL LINE DEVELOPMENT MARKET, KEY COMPANY PROFILES
12.1. BECKMAN COULTER, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CATALENT, INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AGC BIOLOGICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LONZA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SYSMEX EUROPE GMBH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SELEXIS SA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PROBIOGEN AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. THERMO FISHER SCIENTIFIC INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MERCK KGAA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Beckman Coulter, Inc.
2. Boehringer Ingelheim International GmbH
3. Catalent, Inc
4. AGC Biologics
5. Lonza
6. Sysmex Europe GmbH
7. Selexis SA
8. ProBioGen AG
9. Thermo Fisher Scientific Inc.
10. Merck KGaA
TIPRE00007166
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking